Comparison of bleeding risk between colistin– tigecycline and colistin–carbapenem treatment regimens: A retrospective cohort study
Journal
Infection and drug resistance
Journal Volume
14
Pages
4949
Date Issued
2021
Author(s)
Abstract
Antibiotic combination is commonly used to treat multidrug-resistant pathogens. Reports have indicated that tigecycline use is associated with hypofibrinogenemia. However, whether the bleeding risk of tigecycline is higher than that of other antibiotics remains unknown. The aim of this study was to compare the bleeding risk between colistin-tigecycline and colistin-carbapenem treatment.
Subjects
bleeding events; carbapenems; tigecycline
SDGs
Publisher
DOVE MEDICAL PRESS LTD
Type
journal article